Saisubramanian Nagarajan - Infectious Diseases

Author Information

Saisubramanian Nagarajan is a distinguished researcher affiliated with the Center for Research on Infectious Diseases at the School of Chemical and Biotechnology, SASTRA Deemed to be University, located in Thanjavur, Tamil Nadu, India. His work primarily focuses on tackling challenges related to drug-resistant bacterial infections, especially in the context of the emerging 'post-antibiotic era'.

Research Contributions

Saisubramanian Nagarajan has made significant contributions to the field of infectious diseases, particularly in the study and management of drug-resistant bacteria. His research encompasses innovative approaches such as the use of nanoparticles and phage therapy to combat resistant strains of bacteria like Klebsiella pneumoniae and Escherichia coli. Notable studies include exploring the potential of nanoparticles to address drug resistance, the application of phage therapy derived from the Ganges River, and strategies to restore antibiotic sensitivity in resistant bacterial strains.

Aliases

Saisubramanian Nagarajan is also known by the alias "S. Nagarajan".

Publication and Citation Metrics

Metric	Value
Citation Count	623
H-index	15
Paper Count	28

Publications:

Can Nanoparticles Help in the Battle against Drug-Resistant Bacterial Infections in “Post-Antibiotic Era”?

DOI: 10.1007/978-981-16-3120-7_7

Year: 2022

Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model

DOI: 10.1186/s13568-021-01181-0

Year: 2021

Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model

DOI: 10.21203/rs.3.rs-68491/v3

Year: 2021

Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model

DOI: 10.21203/rs.3.rs-68491/v1

Year: 2020

Simultaneous inhibition of MarR by salicylate and efflux pumps by curcumin sensitizes colistin resistant clinical isolates of Enterobacteriaceae.

DOI: 10.1016/j.micpath.2020.104445

Year: 2020

Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model

DOI: 10.21203/rs.3.rs-68491/v2

Year: 2020

Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli

DOI: 10.1038/s41598-019-41489-3

Year: 2019

Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

DOI: 10.1080/1040841X.2019.1607248

Year: 2019

Restoring colistin sensitivity in colistin-resistant E. coli: Combinatorial use of MarR inhibitor with efflux pump inhibitor

DOI: 10.1038/s41598-019-56325-x

Year: 2019

Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae

DOI: 10.1186/s13568-019-0750-4

Year: 2019

What is Aedes Albopictus?

What Role Does Testing Play in Monogamous Relationships?

Why is One Health Important in Infectious Diseases?

How Can Individuals Contribute to One Health?

What is Yellow Fever?

What Are the Primary Methods of Mosquito Control?

Why are Surveillance Systems Important?

What Role Do International Organizations Play?

What are Isoprenoids?

What is Fomite Transmission?

Partnered Content Networks

Relevant Topics